Graphene Transistors for In Vitro Detection of Health Biomarkers

Biomarkers are primary indicators for precise diagnosis and treatment. The early identification of health biomarkers has been sustained by the evolutionary success in sensor technologies. Among them, graphene field‐effect transistor (GFET) biosensors have exhibited major advantages such as an ultrashort response time, high sensitivity, easy operation, capability of integration, and label‐free detection. Owing to the atomic thickness, graphene restricts charge carrier flow merely at the material surface and responds to foreign stimuli directly, leading to effective signal acquisition and transmission. Here, this review summarizes the latest advances in GFET biosensors in a comprehensive manner that contains the device design, working principle, surface functionalization, and proof‐of‐concept applications. It provides a comprehensive survey of GFET biosensors with regard to biomarker analysis at the single‐device level and integrated prototypes that include wearable sensors, biomimetic systems, healthcare electronics, and diagnostic platforms. Moreover, there is discussion on the long‐standing research efforts and outlook for the future development of GFET sensor systems from lab to fab. Recent advances in graphene field‐effect transistor (GFET) biosensors are summarized, including device design and operation, biomarker analysis, and prototypical applications. The advantages and limitations of GFETs and the possible technical solutions to existing challenges are discussed, providing suggestions on the future development of GFET biosensors in biomarker analysis and healthcare monitoring applications.